Alnylam PharmaceuticalsALNY 
$274.950.18%24h
0.18%24h
Global rank529
Market cap$34.34B
Change 7d-
YTD Performance44.80%
SP500 benchmarkOutperform
P/E-78.11
P/S18.78
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
EPS for Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals has an EPS of $-3.52. In 2022, the company made an earnings per share (EPS) of $-9.3. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for ALNY
-
Value:-
EPS history for Alnylam Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$3.52 | -62.15% |
| 2022 | -$9.30 | 29.17% |
| 2021 | -$7.20 | -3.49% |
| 2020 | -$7.46 | - |
View the highest EPS stocks
